During the past decade, Instituto Mederi de Pesquisa e Saude conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Mederi de Pesquisa e Saude" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Enanta Pharmaceuticals, Inc" with 1 trials sponsored and "Guerbet" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Mederi de Pesquisa e Saude" #1 collaborator was "Bayer AG (Sponsor)" with 1 trials as a collaborator, "Bracco (Sponsor)" with 1 trials as a collaborator, "GEHC (Sponsor)" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Mederi de Pesquisa e Saude" are "Acute Respiratory Infection" (1 trials), "COVID-19" (1 trials), "Cognitive Function" (1 trials), "Contrast Media" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Instituto Mederi de Pesquisa e Saude" in a lesser frequency.

Most popular intervention types in "Instituto Mederi de Pesquisa e Saude" are "Drug" (11 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Carboplatin" (2 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Mederi de Pesquisa e Saude" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Mederi de Pesquisa e Saude". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Mederi de Pesquisa e Saude, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Mederi de Pesquisa e Saude, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".